The availability of HCV-positive organs may expand the donor pool and decrease waitlist times and mortality. These data highlight the need for patient education towards use of these organs.
No takes yet. Share an insight, caveat, or question.
Couri et al. (2018) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: